HIV Market 2019-2026
New Market Study, Report “HIV Market 2019 Global Industry Demand, Opportunities, Growth Drivers, Challenges, Strategies and Forecasts 2026” Has been Added on WiseGuyReports.com.
HIV infected population in major markets around the world
This report provides in depth study of “HIV Market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The HIV Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.
The human immunodeficiency virus (HIV) is a lentivirus which results in a persistent viral infection. HIV attacks the immune system and renders the body helpless against various microbial organisms that cause infection and disease. If HIV infection is not detected at an early stage, people can eventually contract AIDS or Acquired Immunodeficiency Syndrome. Acquired Immunodeficiency Syndrome or AIDS is the culmination of HIV infection in human beings. During this final phase of HIV infection, the body loses its ability to combat fatal infections entirely, and becomes susceptible to a vast range of common diseases. The most common means of HIV infection is sexual transmission, but it can also be propagated through infected blood or from mother to child during pregnancy or childbirth, or via breastfeeding (vertical transmission).
A recently published report analyses the current prevalence of HIV infection in eight of the biggest HIV markets, segmented by gender and a five-year age bracket. Apart from the current prevalence, the report also offers an overview of the HIV risk factors, incorporating insightful information about the diagnosis and prognosis of the infection and taking into consideration the regional variations on the basis of geography and ethnicity.
A number of the main symptoms and co-morbidities associated with HIV have been analysed and presented in this report, along with statistics on the overall prevalence of these co-morbidities. Some of the major co-morbidities related to HIV infection are impaired kidney function, AIDS, opportunistic infections, HBC (haemoglobin C), and HCV (hepatitis C). These sub-sections within the main HIV population are analysed at a country level to provide a ten-year forecast of the global HIV population.
Request for Free Sample Report of “HIV” Market @ https://www.wiseguyreports.com/sample-request/3028460-epiomic-epidemiology-series-hiv-forecast-in-8-major-markets-2016-2026
The HIV market can be classified by Type and Region.
The two main types or strains of HIV are HIV-1 and HIV-2. HIV-1 is the most commonly found strain, responsible for approximately ninety-five percent of all infection worldwide. On the other hand, HIV-2 is comparatively uncommon. In 2018, the global HIV infected population was estimated to be 37.9 million, of which 36.2 million were adults and 1.7 million were children under fifteen years of age.
Approximately 1.7 million individuals across the globe became infected with HIV in 2018. Of these new infections, 1.6 million infections were among people ages 15 and older, and 160,000 infections were among children ages 0-14. The report provides essential insights into the spread of these sub-sections (divided on the basis of co-morbidities, age and gender) in the global HIV infected population and identifies the sub-sections which are the most affected.
Geographically, the report covers the HIV population across eight of the largest regional HIV markets in the world, which are the United States of America, France, Germany, Italy, Spain, the United Kingdoms, Brazil and Japan, giving a ten-year forecast of the different sub-sections in the HIV population in these regions.
If you have any special requirements, please let us know and we will offer you the report as you want.
HIV is still one of the foremost causes of death globally, but in recent years, the number of deaths has gone down, thanks largely to the increasing adoption of antiretroviral treatment or ART. AIDS claimed the lives of 770,000 people in 2018, thirty-six percent lesser than the 1.2 million casualties in 2010.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)